Immix Biopharma, Inc. IMMX
8.35 USD -0.22 (-2.57%)
At closeNov 10, 2026, 5:46 PM EST
8.14 -0.21 -2.51%
After hours · Nov 10, 5:46 PM ET
8.13 Day range 8.77
3.23 52-week range 14.47
- YTD
- +59.66%
- 1 year
- +157.72%
Financial health
Altman Z-Score
41.65 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -5.9×
FY 2019 5y median -3.9× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.8×
FY 2019 5y median 2.4× FY 2025
P/FCF -7.0×
FY 2019 5y median -7.0× FY 2025
EV/EBITDA -2.7×
FY 2019 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -14.3%
FY 2019 5y median -14.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -31.4%
FY 2019 5y median -94.0% FY 2025
ROIC -31.6%
FY 2019 5y median -60.3% FY 2025
ROA -28.1%
FY 2019 5y median -77.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -32.1%
FY 2019 FY 2025
EPS (diluted) -17.1%
FY 2019 FY 2025
Free Cash Flow -56.4%
FY 2019 FY 2025
Financial Health
Current Ratio 10.0×
FY 2019 5y median 10.0× FY 2025
Quick Ratio 10.0×
FY 2019 5y median 10.0× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 3.1×
FY 2019 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31